1. Home
  2. INKT vs COEP Comparison

INKT vs COEP Comparison

Compare INKT & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • COEP
  • Stock Information
  • Founded
  • INKT 2017
  • COEP 2017
  • Country
  • INKT United States
  • COEP United States
  • Employees
  • INKT N/A
  • COEP N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INKT Health Care
  • COEP Health Care
  • Exchange
  • INKT Nasdaq
  • COEP Nasdaq
  • Market Cap
  • INKT 43.0M
  • COEP 32.4M
  • IPO Year
  • INKT 2021
  • COEP N/A
  • Fundamental
  • Price
  • INKT $11.00
  • COEP $11.54
  • Analyst Decision
  • INKT Strong Buy
  • COEP
  • Analyst Count
  • INKT 2
  • COEP 0
  • Target Price
  • INKT $6.50
  • COEP N/A
  • AVG Volume (30 Days)
  • INKT 71.7K
  • COEP 136.7K
  • Earning Date
  • INKT 03-20-2025
  • COEP 03-25-2025
  • Dividend Yield
  • INKT N/A
  • COEP N/A
  • EPS Growth
  • INKT N/A
  • COEP N/A
  • EPS
  • INKT N/A
  • COEP N/A
  • Revenue
  • INKT N/A
  • COEP N/A
  • Revenue This Year
  • INKT N/A
  • COEP N/A
  • Revenue Next Year
  • INKT N/A
  • COEP N/A
  • P/E Ratio
  • INKT N/A
  • COEP N/A
  • Revenue Growth
  • INKT N/A
  • COEP N/A
  • 52 Week Low
  • INKT $4.56
  • COEP $2.31
  • 52 Week High
  • INKT $19.00
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • INKT 59.75
  • COEP 59.40
  • Support Level
  • INKT $7.32
  • COEP $8.65
  • Resistance Level
  • INKT $13.79
  • COEP $13.70
  • Average True Range (ATR)
  • INKT 2.07
  • COEP 2.11
  • MACD
  • INKT 0.28
  • COEP -0.24
  • Stochastic Oscillator
  • INKT 71.94
  • COEP 61.22

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: